FDA Approves Dose Escalation Label Update for Puma Biotechnology's NERLYNX® (neratinib) in HER2-Positive Early Stage and Metastatic Breast Cancer | Business Wire
What Type Of Shareholders Own The Most Number of Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares?